At 20/20 Onsite, we specialize in delivering comprehensive mobile ophthalmic solutions that streamline every phase of clinical trials. Our mobile eye services integrate seamlessly into your study—from thorough protocol reviews and precise prescreening to optimizing patient enrollment and retention strategies—ensuring superior study outcomes. By efficiently integrating assessments, we provide a holistic approach to clinical trials that meets the rigorous standards of clinical research.
Screening timelines met across all business operations.
Data accuracy submission rate.
Patient retention rate vs industry standard 70%.
Patient NPS score.
We ensure that every aspect of your study is aligned with its ocular endpoints, resulting in compliant trial designs that meet critical timelines and schedules. With a proven track record of refining protocols for numerous multi-center studies, we consistently improve clinical trial outcomes.
Our prescreening process harnesses advanced analytics and targeted outreach to identify the candidates for your clinical study. By thoroughly evaluating patient profiles early on, we significantly reduce screening times and ensure that only the best-fit participants move forward.
Our patient enrollment strategy is centered on creating a smooth and engaging enrollment process that minimizes barriers to entry. We combine point-of-need assessments with personalized support to efficiently enroll patients while strictly adhering to regulatory standards.
We integrate directly into your clinical trial workflow, ensuring that each ophthalmic assessment perfectly aligns with study requirements and does not disrupt your current site workflow. This integration reduces disruptions and maintains the integrity of critical data throughout the trial.
Our retention strategy recognizes that ongoing patient engagement is vital for trial success and emphasizes continuous communication and point-of-need support. We proactively keep participants informed, engaged, and motivated throughout the study.
Ensure that trial patients continue to receive the follow-up assessments required by your study, wherever they are. Our point-of-need assessments help analyze long-term outcomes to keep patient safety at the forefront.
Support for ophthalmic assessments or other study-specific eye-related solutions as part of a research protocol.
Support for safety or surveillance ophthalmic assessments and eye-related clinical trial solutions for patients outside of a clinical protocol.
The Industry and Scientific Advisory Board (IASAB) meets quarterly to help identify patient needs, product opportunities, and market challenges associated with the provision of vision-related assessments for clinical trials and safety surveillance.
CEO and President Retina Global
Founder and CEO JTH Consulting, LLC
Director of the Vitreoretinal Service and Director of Retina Research Ophthalmic Consultants of Boston (OCB)
Chaney Family Endowed Chair in Ophthalmology Research and Professor of Ophthalmology Cleveland Clinic Lerner College of Medicine
Vice President of North America Sales and Marketing, Ophthalmology Apellis Pharmaceuticals
Chief Operating Officer Foundation Fighting Blindness
Owner Socialite Vision
Click below to read more about each board member's commitment to research or submit a question to be asked during our next quarterly meeting.
Fully equipped clinics on wheels providing comprehensive ophthalmic assessments essentially anywhere, eliminating geographical barriers.
Semi-permanent examination spaces that can be easily set up and customized per specific study requirements. MVPs can be deployed externally at research sites or convenient locations for extended periods.
Portable solutions that bring ophthalmic equipment and certified staff to existing exam rooms and suitable facilities.
Our newsletter dedicated to clinical research, insights on patient-centric treatments, and point-of-need clinical trial solutions.
Copyright © 2025. | Privacy Policy